BlackRock’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52K Sell
992
-15,276
-94% -$23.4K ﹤0.01% 5263
2025
Q1
$20K Sell
16,268
-291
-2% -$358 ﹤0.01% 5045
2024
Q4
$51.5K Sell
16,559
-2,447
-13% -$7.61K ﹤0.01% 4886
2024
Q3
$53.6K Buy
19,006
+7,980
+72% +$22.5K ﹤0.01% 4748
2024
Q2
$59.9K Buy
11,026
+10,034
+1,011% +$54.5K ﹤0.01% 4773
2024
Q1
$4.27K Sell
992
-372
-27% -$1.6K ﹤0.01% 5086
2023
Q4
$7.5K Hold
1,364
﹤0.01% 5093
2023
Q3
$6.19K Sell
1,364
-544
-29% -$2.47K ﹤0.01% 5161
2023
Q2
$5.92K Hold
1,908
﹤0.01% 5206
2023
Q1
$1.35K Sell
1,908
-10,847
-85% -$7.7K ﹤0.01% 5374
2022
Q4
$33.9K Buy
12,755
+1,003
+9% +$2.67K ﹤0.01% 5222
2022
Q3
$43K Sell
11,752
-344
-3% -$1.26K ﹤0.01% 5302
2022
Q2
$40K Sell
12,096
-14,141
-54% -$46.8K ﹤0.01% 5369
2022
Q1
$115K Sell
26,237
-587
-2% -$2.57K ﹤0.01% 5167
2021
Q4
$255K Buy
26,824
+919
+4% +$8.74K ﹤0.01% 4978
2021
Q3
$438K Buy
25,905
+50
+0.2% +$845 ﹤0.01% 4728
2021
Q2
$722K Sell
25,855
-181,749
-88% -$5.08M ﹤0.01% 4535
2021
Q1
$4.65M Buy
207,604
+962
+0.5% +$21.5K ﹤0.01% 3911
2020
Q4
$3M Buy
206,642
+10,320
+5% +$150K ﹤0.01% 3826
2020
Q3
$2.95M Sell
196,322
-709
-0.4% -$10.6K ﹤0.01% 3689
2020
Q2
$4.08M Buy
197,031
+6,267
+3% +$130K ﹤0.01% 3530
2020
Q1
$3.62M Sell
190,764
-1,981
-1% -$37.6K ﹤0.01% 3409
2019
Q4
$5.55M Buy
192,745
+9,210
+5% +$265K ﹤0.01% 3423
2019
Q3
$9.38M Buy
183,535
+5,460
+3% +$279K ﹤0.01% 3205
2019
Q2
$14.1M Buy
178,075
+163,023
+1,083% +$12.9M ﹤0.01% 3013
2019
Q1
$994K Buy
15,052
+13,145
+689% +$868K ﹤0.01% 3870
2018
Q4
$106K Sell
1,907
-192
-9% -$10.7K ﹤0.01% 4302
2018
Q3
$190K Buy
2,099
+85
+4% +$7.69K ﹤0.01% 4261
2018
Q2
$189K Buy
2,014
+609
+43% +$57.2K ﹤0.01% 4260
2018
Q1
$47K Sell
1,405
-36
-2% -$1.2K ﹤0.01% 4394
2017
Q4
$57K Buy
1,441
+58
+4% +$2.29K ﹤0.01% 4358
2017
Q3
$42K Sell
1,383
-80
-5% -$2.43K ﹤0.01% 4437
2017
Q2
$57K Buy
+1,463
New +$57K ﹤0.01% 4435